Abbott Laboratories (ABT)
Return on equity (ROE)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 13,977,000 | 13,979,000 | 13,502,000 | 13,402,000 | 5,767,000 | 5,557,000 | 5,630,000 | 5,723,000 | 5,162,000 | 5,161,000 | 5,804,000 | 6,933,000 | 7,889,000 | 8,554,000 | 7,725,000 | 7,071,000 | 7,244,000 | 6,376,000 | 5,724,000 | 4,495,000 |
| Total stockholders’ equity | US$ in thousands | 50,954,000 | 50,565,000 | 48,811,000 | 47,664,000 | 39,796,000 | 39,318,000 | 38,810,000 | 38,603,000 | 37,481,000 | 37,174,000 | 74,219,000 | 36,686,000 | 35,675,000 | 36,490,000 | 35,399,000 | 35,802,000 | 34,422,000 | 33,800,000 | 33,562,000 | 32,784,000 |
| ROE | 27.43% | 27.65% | 27.66% | 28.12% | 14.49% | 14.13% | 14.51% | 14.83% | 13.77% | 13.88% | 7.82% | 18.90% | 22.11% | 23.44% | 21.82% | 19.75% | 21.04% | 18.86% | 17.06% | 13.71% |
September 30, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $13,977,000K ÷ $50,954,000K
= 27.43%
Peer comparison
Sep 30, 2025
Company name
Symbol
ROE
Abbott Laboratories
ABT
27.43%
CONMED Corporation
CNMD
6.35%
Stryker Corporation
SYK
14.48%